These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

802 related items for PubMed ID: 35176079

  • 41. Effect of AMP-activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population.
    Li Q, Li C, Li H, Zeng L, Kang Z, Mao Y, Tang X, Zheng P, He L, Luo F, Li Z.
    J Diabetes; 2018 Jan; 10(1):43-49. PubMed ID: 28322508
    [Abstract] [Full Text] [Related]

  • 42. Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; evidence from Kurdish patients with type 2 diabetes mellitus.
    Amini S, Javanmardi M, Mokarizadeh A, Maroofi F, Jalali C, Azadi NA, Mohammadi H, Abdi M.
    QJM; 2016 Jun; 109(6):399-404. PubMed ID: 26337659
    [Abstract] [Full Text] [Related]

  • 43. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.
    Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.
    Diabetes Care; 2003 Aug; 26(8):2410-5. PubMed ID: 12882871
    [Abstract] [Full Text] [Related]

  • 44. Interleukin-1β Gene (IL1B) Polymorphism and Risk of Developing Diabetic Nephropathy.
    Buraczynska M, Ksiazek K, Wacinski P, Zaluska W.
    Immunol Invest; 2019 Aug; 48(6):577-584. PubMed ID: 31044637
    [Abstract] [Full Text] [Related]

  • 45. A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group.
    Schmidt S, Blüthner M, Giessel R, Strojek K, Bergis KH, Grzeszczak W, Ritz E.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1807-10. PubMed ID: 9681733
    [Abstract] [Full Text] [Related]

  • 46. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
    Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M.
    J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Role of DNA repair genes XRCC3 and XRCC1 in predisposition to type 2 diabetes mellitus and diabetic nephropathy.
    Yesil-Devecioglu T, Dayan A, Demirtunc R, Sardas S.
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):90-98. PubMed ID: 30472145
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
    Schmidt S, Schöne N, Ritz E.
    Kidney Int; 1995 Apr; 47(4):1176-81. PubMed ID: 7783416
    [Abstract] [Full Text] [Related]

  • 51. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Möllsten A, Vionnet N, Forsblom C, Parkkonen M, Tarnow L, Hadjadj S, Marre M, Parving HH, Groop PH.
    Mol Genet Metab; 2011 May; 103(1):66-70. PubMed ID: 21316998
    [Abstract] [Full Text] [Related]

  • 52. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M, Zibar L, Glavas-Obrovac- L, Stefanić M, Avdicević M, Barbić J.
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Novel ERBB receptor feedback inhibitor 1 (ERRFI1) + 808 T/G polymorphism confers protective effect on diabetic nephropathy in a Korean population.
    Lee IS, Lee JH, Kim HJ, Lee JM, Lee SK, Kim HS, Lee JM, Park KS, Ku BJ.
    Dis Markers; 2013 Oct; 34(2):113-24. PubMed ID: 23324575
    [Abstract] [Full Text] [Related]

  • 55. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.
    Schmidt S, Ritz E.
    Nephrol Dial Transplant; 1997 Oct; 12 Suppl 2():37-41. PubMed ID: 9269698
    [Abstract] [Full Text] [Related]

  • 56. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes.
    Wu JC, Li XH, Peng YD, Wang JB, Tang JF, Wang YF.
    J Endocrinol Invest; 2011 Nov; 34(10):e343-8. PubMed ID: 21738003
    [Abstract] [Full Text] [Related]

  • 57. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.
    Wong TY, Poon P, Chow KM, Szeto CC, Cheung MK, Li PK.
    Kidney Int; 2003 May; 63(5):1831-5. PubMed ID: 12675860
    [Abstract] [Full Text] [Related]

  • 58. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy.
    Ha SK, Park HC, Park HS, Kang BS, Lee TH, Hwang HJ, Kim SJ, Kim DH, Kang SW, Choi KH, Lee HY, Han DS.
    Am J Kidney Dis; 2003 May; 41(5):943-9. PubMed ID: 12722028
    [Abstract] [Full Text] [Related]

  • 59. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
    Buraczynska M, Zukowski P, Ksiazek K, Wacinski P, Dragan M.
    Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
    [Abstract] [Full Text] [Related]

  • 60. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M.
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.